Today's Top Stories


Hot Topics


Comment & Analysis »

GlobalData Healthcare

Majority of UC Cases Considered Mild to Moderate

Publication Date: Month 2017 Ulcerative colitis (UC) can be a significant cause of morbidity and worsen the quality of life for individuals with the disease, especially in its most severe form....

Majority of UC Cases Considered Mild to Moderate
GlobalData Healthcare

Generic antibiotics are more important than ever, but supply shortages threaten their usefulness

Generic antibiotics are more important than ever, but supply shortages threaten their usefulness
GlobalData Healthcare

The Human Microbiome: On the cutting edge of future cures for many diseases?

The Human Microbiome: On the cutting edge of future cures for many diseases?
GlobalData Healthcare

Novel diagnostics: supporting empiric therapy for suspected UTIs

Novel diagnostics: supporting empiric therapy for suspected UTIs
GlobalData Healthcare

New Data Released for Roche’s Latest Game-Changing Drug for Multiple Sclerosis

New Data Released for Roche’s Latest Game-Changing Drug for Multiple Sclerosis

Company Releases »

Analysing Polysaccharides Using OMNISEC

Malvern Instruments
Analysing Polysaccharides Using OMNISEC

Biopharmaceutical and Drug Development

Malvern Instruments
Biopharmaceutical and Drug Development

Application: Operating Reactor Systems for Process Research and Development

SYSTAG Systems Technik Application: Operating Reactor Systems for Process Research and Development

Paradigm Shift Regarding API and Formulation Components

Pfanstiehl
Paradigm Shift Regarding API and Formulation Components

Optimising Development Resources for Efficient Product Development

SYSTAG Systems Technik Optimising Development Resources for Efficient Product Development

Drugdevelopment Insights »

Drugdevelopment Industry Reports »

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

Report: Non-alcoholic steatohepatitis market to witness CAGR of 45%

Report: Non-alcoholic steatohepatitis market to witness CAGR of 45%

Report: HIV market to grow marginally at CAGR of 3% by 2025

Report: HIV market to grow marginally at CAGR of 3% by 2025

Report: New standard-of-care maintenance therapies to drive growth of ovarian cancer market to $5.2bn by 2025

Report: New standard-of-care maintenance therapies to drive growth of ovarian cancer market to $5.2bn by 2025








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115